 | • レポートコード：QYR2104Z3693 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、メンデル遺伝病検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（保因者検査、診断検査、新生児スクリーニング、予測・発症前検査、出生前検査）、用途別市場規模（病院、専門病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・メンデル遺伝病検査の市場動向 ・企業の競争状況、市場シェア ・メンデル遺伝病検査の種類別市場規模（保因者検査、診断検査、新生児スクリーニング、予測・発症前検査、出生前検査） ・メンデル遺伝病検査の用途別市場規模（病院、専門病院、その他） ・メンデル遺伝病検査の北米市場規模2016-2027（アメリカ、カナダ） ・メンデル遺伝病検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・メンデル遺伝病検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・メンデル遺伝病検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・メンデル遺伝病検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Celera Group、Abbott Laboratories、ELITech Group、Quest Diagnostics、AutoGenomics、PerkinElmer、Roche Diagnostics、Bio-Rad Laboratories、Applied Biosystems、Transgenomic） ・結論 |
The Mendelian disorder is different types of genetic disorder in humans. These genetic disorders are mainly caused by the changes or alterations in a single gene or due to the abnormalities in the genome. These conditions will be present since the child’s birth and can be predicted based on the history of a family with the help of a family tree. This process of analysis is called the pedigree analysis.
The different types of Mendelian disorders can be easily determined from the pedigree analysis. Few examples of the Mendelian disorder in humans are Sickle cell anemia, color blindness, muscular dystrophy, Thalassemia, cystic fibrosis, skeletal dysplasia, hemophilia, and phenylketonuria are the most common Mendelian disorders.
Market Analysis and Insights: Global Mendelian Disorders Testing Market
The global Mendelian Disorders Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mendelian Disorders Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mendelian Disorders Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mendelian Disorders Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mendelian Disorders Testing market.
Global Mendelian Disorders Testing Scope and Market Size
Mendelian Disorders Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mendelian Disorders Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive & Pre-Symptomatic Testing
Prenatal Testing
Segment by Application
Hospitals
Specialty Clinc
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Celera Group
Abbott Laboratories
ELITech Group
Quest Diagnostics
AutoGenomics
PerkinElmer
Roche Diagnostics
Bio-Rad Laboratories
Applied Biosystems
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mendelian Disorders Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Carrier Testing
1.2.3 Diagnostic Testing
1.2.4 New-Born Screening
1.2.5 Predictive & Pre-Symptomatic Testing
1.2.6 Prenatal Testing
1.3 Market by Application
1.3.1 Global Mendelian Disorders Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinc
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mendelian Disorders Testing Market Perspective (2016-2027)
2.2 Mendelian Disorders Testing Growth Trends by Regions
2.2.1 Mendelian Disorders Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Mendelian Disorders Testing Historic Market Share by Regions (2016-2021)
2.2.3 Mendelian Disorders Testing Forecasted Market Size by Regions (2022-2027)
2.3 Mendelian Disorders Testing Industry Dynamic
2.3.1 Mendelian Disorders Testing Market Trends
2.3.2 Mendelian Disorders Testing Market Drivers
2.3.3 Mendelian Disorders Testing Market Challenges
2.3.4 Mendelian Disorders Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mendelian Disorders Testing Players by Revenue
3.1.1 Global Top Mendelian Disorders Testing Players by Revenue (2016-2021)
3.1.2 Global Mendelian Disorders Testing Revenue Market Share by Players (2016-2021)
3.2 Global Mendelian Disorders Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mendelian Disorders Testing Revenue
3.4 Global Mendelian Disorders Testing Market Concentration Ratio
3.4.1 Global Mendelian Disorders Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mendelian Disorders Testing Revenue in 2020
3.5 Mendelian Disorders Testing Key Players Head office and Area Served
3.6 Key Players Mendelian Disorders Testing Product Solution and Service
3.7 Date of Enter into Mendelian Disorders Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mendelian Disorders Testing Breakdown Data by Type
4.1 Global Mendelian Disorders Testing Historic Market Size by Type (2016-2021)
4.2 Global Mendelian Disorders Testing Forecasted Market Size by Type (2022-2027)
5 Mendelian Disorders Testing Breakdown Data by Application
5.1 Global Mendelian Disorders Testing Historic Market Size by Application (2016-2021)
5.2 Global Mendelian Disorders Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Mendelian Disorders Testing Market Size (2016-2027)
6.2 North America Mendelian Disorders Testing Market Size by Type
6.2.1 North America Mendelian Disorders Testing Market Size by Type (2016-2021)
6.2.2 North America Mendelian Disorders Testing Market Size by Type (2022-2027)
6.2.3 North America Mendelian Disorders Testing Market Size by Type (2016-2027)
6.3 North America Mendelian Disorders Testing Market Size by Application
6.3.1 North America Mendelian Disorders Testing Market Size by Application (2016-2021)
6.3.2 North America Mendelian Disorders Testing Market Size by Application (2022-2027)
6.3.3 North America Mendelian Disorders Testing Market Size by Application (2016-2027)
6.4 North America Mendelian Disorders Testing Market Size by Country
6.4.1 North America Mendelian Disorders Testing Market Size by Country (2016-2021)
6.4.2 North America Mendelian Disorders Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Mendelian Disorders Testing Market Size (2016-2027)
7.2 Europe Mendelian Disorders Testing Market Size by Type
7.2.1 Europe Mendelian Disorders Testing Market Size by Type (2016-2021)
7.2.2 Europe Mendelian Disorders Testing Market Size by Type (2022-2027)
7.2.3 Europe Mendelian Disorders Testing Market Size by Type (2016-2027)
7.3 Europe Mendelian Disorders Testing Market Size by Application
7.3.1 Europe Mendelian Disorders Testing Market Size by Application (2016-2021)
7.3.2 Europe Mendelian Disorders Testing Market Size by Application (2022-2027)
7.3.3 Europe Mendelian Disorders Testing Market Size by Application (2016-2027)
7.4 Europe Mendelian Disorders Testing Market Size by Country
7.4.1 Europe Mendelian Disorders Testing Market Size by Country (2016-2021)
7.4.2 Europe Mendelian Disorders Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Mendelian Disorders Testing Market Size (2016-2027)
8.2 Asia-Pacific Mendelian Disorders Testing Market Size by Type
8.2.1 Asia-Pacific Mendelian Disorders Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Mendelian Disorders Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Mendelian Disorders Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Mendelian Disorders Testing Market Size by Application
8.3.1 Asia-Pacific Mendelian Disorders Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Mendelian Disorders Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Mendelian Disorders Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Mendelian Disorders Testing Market Size by Region
8.4.1 Asia-Pacific Mendelian Disorders Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Mendelian Disorders Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Mendelian Disorders Testing Market Size (2016-2027)
9.2 Latin America Mendelian Disorders Testing Market Size by Type
9.2.1 Latin America Mendelian Disorders Testing Market Size by Type (2016-2021)
9.2.2 Latin America Mendelian Disorders Testing Market Size by Type (2022-2027)
9.2.3 Latin America Mendelian Disorders Testing Market Size by Type (2016-2027)
9.3 Latin America Mendelian Disorders Testing Market Size by Application
9.3.1 Latin America Mendelian Disorders Testing Market Size by Application (2016-2021)
9.3.2 Latin America Mendelian Disorders Testing Market Size by Application (2022-2027)
9.3.3 Latin America Mendelian Disorders Testing Market Size by Application (2016-2027)
9.4 Latin America Mendelian Disorders Testing Market Size by Country
9.4.1 Latin America Mendelian Disorders Testing Market Size by Country (2016-2021)
9.4.2 Latin America Mendelian Disorders Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mendelian Disorders Testing Market Size (2016-2027)
10.2 Middle East & Africa Mendelian Disorders Testing Market Size by Type
10.2.1 Middle East & Africa Mendelian Disorders Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Mendelian Disorders Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Mendelian Disorders Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Mendelian Disorders Testing Market Size by Application
10.3.1 Middle East & Africa Mendelian Disorders Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Mendelian Disorders Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Mendelian Disorders Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Mendelian Disorders Testing Market Size by Country
10.4.1 Middle East & Africa Mendelian Disorders Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Mendelian Disorders Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Celera Group
11.1.1 Celera Group Company Details
11.1.2 Celera Group Business Overview
11.1.3 Celera Group Mendelian Disorders Testing Introduction
11.1.4 Celera Group Revenue in Mendelian Disorders Testing Business (2016-2021)
11.1.5 Celera Group Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Mendelian Disorders Testing Introduction
11.2.4 Abbott Laboratories Revenue in Mendelian Disorders Testing Business (2016-2021)
11.2.5 Abbott Laboratories Recent Development
11.3 ELITech Group
11.3.1 ELITech Group Company Details
11.3.2 ELITech Group Business Overview
11.3.3 ELITech Group Mendelian Disorders Testing Introduction
11.3.4 ELITech Group Revenue in Mendelian Disorders Testing Business (2016-2021)
11.3.5 ELITech Group Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Details
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Mendelian Disorders Testing Introduction
11.4.4 Quest Diagnostics Revenue in Mendelian Disorders Testing Business (2016-2021)
11.4.5 Quest Diagnostics Recent Development
11.5 AutoGenomics
11.5.1 AutoGenomics Company Details
11.5.2 AutoGenomics Business Overview
11.5.3 AutoGenomics Mendelian Disorders Testing Introduction
11.5.4 AutoGenomics Revenue in Mendelian Disorders Testing Business (2016-2021)
11.5.5 AutoGenomics Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Details
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer Mendelian Disorders Testing Introduction
11.6.4 PerkinElmer Revenue in Mendelian Disorders Testing Business (2016-2021)
11.6.5 PerkinElmer Recent Development
11.7 Roche Diagnostics
11.7.1 Roche Diagnostics Company Details
11.7.2 Roche Diagnostics Business Overview
11.7.3 Roche Diagnostics Mendelian Disorders Testing Introduction
11.7.4 Roche Diagnostics Revenue in Mendelian Disorders Testing Business (2016-2021)
11.7.5 Roche Diagnostics Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Details
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Mendelian Disorders Testing Introduction
11.8.4 Bio-Rad Laboratories Revenue in Mendelian Disorders Testing Business (2016-2021)
11.8.5 Bio-Rad Laboratories Recent Development
11.9 Applied Biosystems
11.9.1 Applied Biosystems Company Details
11.9.2 Applied Biosystems Business Overview
11.9.3 Applied Biosystems Mendelian Disorders Testing Introduction
11.9.4 Applied Biosystems Revenue in Mendelian Disorders Testing Business (2016-2021)
11.9.5 Applied Biosystems Recent Development
11.10 Transgenomic
11.10.1 Transgenomic Company Details
11.10.2 Transgenomic Business Overview
11.10.3 Transgenomic Mendelian Disorders Testing Introduction
11.10.4 Transgenomic Revenue in Mendelian Disorders Testing Business (2016-2021)
11.10.5 Transgenomic Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Mendelian Disorders Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Carrier Testing
Table 3. Key Players of Diagnostic Testing
Table 4. Key Players of New-Born Screening
Table 5. Key Players of Predictive & Pre-Symptomatic Testing
Table 6. Key Players of Prenatal Testing
Table 7. Global Mendelian Disorders Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Mendelian Disorders Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Mendelian Disorders Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Mendelian Disorders Testing Market Share by Regions (2016-2021)
Table 11. Global Mendelian Disorders Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Mendelian Disorders Testing Market Share by Regions (2022-2027)
Table 13. Mendelian Disorders Testing Market Trends
Table 14. Mendelian Disorders Testing Market Drivers
Table 15. Mendelian Disorders Testing Market Challenges
Table 16. Mendelian Disorders Testing Market Restraints
Table 17. Global Mendelian Disorders Testing Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Mendelian Disorders Testing Market Share by Players (2016-2021)
Table 19. Global Top Mendelian Disorders Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mendelian Disorders Testing as of 2020)
Table 20. Ranking of Global Top Mendelian Disorders Testing Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Mendelian Disorders Testing Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Mendelian Disorders Testing Product Solution and Service
Table 24. Date of Enter into Mendelian Disorders Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Mendelian Disorders Testing Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Mendelian Disorders Testing Revenue Market Share by Type (2016-2021)
Table 28. Global Mendelian Disorders Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Mendelian Disorders Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Mendelian Disorders Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Mendelian Disorders Testing Revenue Market Share by Application (2016-2021)
Table 32. Global Mendelian Disorders Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Mendelian Disorders Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Mendelian Disorders Testing Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Mendelian Disorders Testing Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Mendelian Disorders Testing Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Mendelian Disorders Testing Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Mendelian Disorders Testing Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Mendelian Disorders Testing Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Mendelian Disorders Testing Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Mendelian Disorders Testing Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Mendelian Disorders Testing Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Mendelian Disorders Testing Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Mendelian Disorders Testing Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Mendelian Disorders Testing Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Mendelian Disorders Testing Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Mendelian Disorders Testing Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Mendelian Disorders Testing Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Mendelian Disorders Testing Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Mendelian Disorders Testing Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Mendelian Disorders Testing Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Mendelian Disorders Testing Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Mendelian Disorders Testing Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Mendelian Disorders Testing Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Mendelian Disorders Testing Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Mendelian Disorders Testing Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Mendelian Disorders Testing Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Mendelian Disorders Testing Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Mendelian Disorders Testing Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Mendelian Disorders Testing Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Mendelian Disorders Testing Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Mendelian Disorders Testing Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Mendelian Disorders Testing Market Size by Country (2022-2027) & (US$ Million)
Table 64. Celera Group Company Details
Table 65. Celera Group Business Overview
Table 66. Celera Group Mendelian Disorders Testing Product
Table 67. Celera Group Revenue in Mendelian Disorders Testing Business (2016-2021) & (US$ Million)
Table 68. Celera Group Recent Development
Table 69. Abbott Laboratories Company Details
Table 70. Abbott Laboratories Business Overview
Table 71. Abbott Laboratories Mendelian Disorders Testing Product
Table 72. Abbott Laboratories Revenue in Mendelian Disorders Testing Business (2016-2021) & (US$ Million)
Table 73. Abbott Laboratories Recent Development
Table 74. ELITech Group Company Details
Table 75. ELITech Group Business Overview
Table 76. ELITech Group Mendelian Disorders Testing Product
Table 77. ELITech Group Revenue in Mendelian Disorders Testing Business (2016-2021) & (US$ Million)
Table 78. ELITech Group Recent Development
Table 79. Quest Diagnostics Company Details
Table 80. Quest Diagnostics Business Overview
Table 81. Quest Diagnostics Mendelian Disorders Testing Product
Table 82. Quest Diagnostics Revenue in Mendelian Disorders Testing Business (2016-2021) & (US$ Million)
Table 83. Quest Diagnostics Recent Development
Table 84. AutoGenomics Company Details
Table 85. AutoGenomics Business Overview
Table 86. AutoGenomics Mendelian Disorders Testing Product
Table 87. AutoGenomics Revenue in Mendelian Disorders Testing Business (2016-2021) & (US$ Million)
Table 88. AutoGenomics Recent Development
Table 89. PerkinElmer Company Details
Table 90. PerkinElmer Business Overview
Table 91. PerkinElmer Mendelian Disorders Testing Product
Table 92. PerkinElmer Revenue in Mendelian Disorders Testing Business (2016-2021) & (US$ Million)
Table 93. PerkinElmer Recent Development
Table 94. Roche Diagnostics Company Details
Table 95. Roche Diagnostics Business Overview
Table 96. Roche Diagnostics Mendelian Disorders Testing Product
Table 97. Roche Diagnostics Revenue in Mendelian Disorders Testing Business (2016-2021) & (US$ Million)
Table 98. Roche Diagnostics Recent Development
Table 99. Bio-Rad Laboratories Company Details
Table 100. Bio-Rad Laboratories Business Overview
Table 101. Bio-Rad Laboratories Revenue in Mendelian Disorders Testing Business (2016-2021) & (US$ Million)
Table 102. Bio-Rad Laboratories Recent Development
Table 103. Applied Biosystems Company Details
Table 104. Applied Biosystems Business Overview
Table 105. Applied Biosystems Mendelian Disorders Testing Product
Table 106. Applied Biosystems Revenue in Mendelian Disorders Testing Business (2016-2021) & (US$ Million)
Table 107. Applied Biosystems Recent Development
Table 108. Transgenomic Company Details
Table 109. Transgenomic Business Overview
Table 110. Transgenomic Mendelian Disorders Testing Product
Table 111. Transgenomic Revenue in Mendelian Disorders Testing Business (2016-2021) & (US$ Million)
Table 112. Transgenomic Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mendelian Disorders Testing Market Share by Type: 2020 VS 2027
Figure 2. Carrier Testing Features
Figure 3. Diagnostic Testing Features
Figure 4. New-Born Screening Features
Figure 5. Predictive & Pre-Symptomatic Testing Features
Figure 6. Prenatal Testing Features
Figure 7. Global Mendelian Disorders Testing Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Specialty Clinc Case Studies
Figure 10. Others Case Studies
Figure 11. Mendelian Disorders Testing Report Years Considered
Figure 12. Global Mendelian Disorders Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Mendelian Disorders Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Mendelian Disorders Testing Market Share by Regions: 2020 VS 2027
Figure 15. Global Mendelian Disorders Testing Market Share by Regions (2022-2027)
Figure 16. Global Mendelian Disorders Testing Market Share by Players in 2020
Figure 17. Global Top Mendelian Disorders Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mendelian Disorders Testing as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Mendelian Disorders Testing Revenue in 2020
Figure 19. Global Mendelian Disorders Testing Revenue Market Share by Type (2016-2021)
Figure 20. Global Mendelian Disorders Testing Revenue Market Share by Type (2022-2027)
Figure 21. North America Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Mendelian Disorders Testing Market Share by Type (2016-2027)
Figure 23. North America Mendelian Disorders Testing Market Share by Application (2016-2027)
Figure 24. North America Mendelian Disorders Testing Market Share by Country (2016-2027)
Figure 25. United States Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Mendelian Disorders Testing Market Share by Type (2016-2027)
Figure 29. Europe Mendelian Disorders Testing Market Share by Application (2016-2027)
Figure 30. Europe Mendelian Disorders Testing Market Share by Country (2016-2027)
Figure 31. Germany Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Mendelian Disorders Testing Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Mendelian Disorders Testing Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Mendelian Disorders Testing Market Share by Region (2016-2027)
Figure 41. China Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Mendelian Disorders Testing Market Share by Type (2016-2027)
Figure 49. Latin America Mendelian Disorders Testing Market Share by Application (2016-2027)
Figure 50. Latin America Mendelian Disorders Testing Market Share by Country (2016-2027)
Figure 51. Mexico Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Mendelian Disorders Testing Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Mendelian Disorders Testing Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Mendelian Disorders Testing Market Share by Country (2016-2027)
Figure 57. Turkey Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Mendelian Disorders Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Celera Group Revenue Growth Rate in Mendelian Disorders Testing Business (2016-2021)
Figure 61. Abbott Laboratories Revenue Growth Rate in Mendelian Disorders Testing Business (2016-2021)
Figure 62. ELITech Group Revenue Growth Rate in Mendelian Disorders Testing Business (2016-2021)
Figure 63. Quest Diagnostics Revenue Growth Rate in Mendelian Disorders Testing Business (2016-2021)
Figure 64. AutoGenomics Revenue Growth Rate in Mendelian Disorders Testing Business (2016-2021)
Figure 65. PerkinElmer Revenue Growth Rate in Mendelian Disorders Testing Business (2016-2021)
Figure 66. Roche Diagnostics Revenue Growth Rate in Mendelian Disorders Testing Business (2016-2021)
Figure 67. Bio-Rad Laboratories Revenue Growth Rate in Mendelian Disorders Testing Business (2016-2021)
Figure 68. Applied Biosystems Revenue Growth Rate in Mendelian Disorders Testing Business (2016-2021)
Figure 69. Transgenomic Revenue Growth Rate in Mendelian Disorders Testing Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の出生前遺伝子検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Prenatal Genetic Testing Market The global Prenatal Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …- 世界の出生前検査市場規模・現状・予測（2021年-2027年） Prenatal testing consists of prenatal screening and prenatal diagnosis, which are aspects of prenatal care that focus on detecting problems with the pregnancy as early as possible. Prenatal screening can detect problems such as neural tube defects, chromosome abnormalities, and it can also detect an…
- 世界の非侵襲的出生前検査市場規模・現状・予測（2021年-2027年） Non-Invasive Prenatal Testing is a method of determining the risk that the fetus will be born with certain genetic abnormalities. This testing analyzes small fragments of DNA that are circulating in a pregnant woman's blood Market Analysis and Insights: Global Non-Invasive Prenatal Testing Market Th…
- 世界の遺伝子診断検査＆消費者向け/健康用ゲノミクス市場規模・現状・予測（2021年-2027年） Predictive genetic testing is relatively new but rapidly emerging arena in public health practices, especially in developed nations. It is increasingly being used to guide nutritional strategies and training outcomes for a number of disorders. While wellness genomics is used to assist persons to tak…
- 世界の豚診断検査市場規模・現状・予測（2021年-2027年） Swine diagnostic testing is extremely important for pork breeders to keep adverse effects on production and minimum economic losses. Growing consumption of pork meat is expected to be the prime factor driving the growth of global swine diagnostic testing market. Market Analysis and Insights: Global …